Live feed
·
PRReleasevia Quantisnow
DBV Technologies S.A. logo

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
DBVT· DBV Technologies S.A.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DBVT (DBV Technologies S.A.) and more on Quantisnow.